Navigation Links
CASA* Evaluation of Welfare Demonstration Program in New Jersey Finds Effective Approach to Addiction Recovery and Employment

Corresponding American Journal of Public Health Article Reveals Intensive Case Management Helps Substance-Abusing Women on Welfare Achieve Goals of Welfare Reform

NEW YORK, Jan. 29 /PRNewswire-USNewswire/ -- A new approach to helping drug-addicted women on welfare that treats substance abuse and addiction as a chronic disease promises better outcomes of sobriety and employment than current approaches that focus on employment first, according to CASASARD(SM): Intensive Case Management for Substance-Dependent Women Receiving Temporary Assistance for Needy Families, a new White Paper by The National Center on Addiction and Substance Abuse (CASA) at Columbia University.


CASASARD(SM)(1), an ongoing welfare demonstration program for drug-addicted mothers conducted in Essex (including Newark) and Atlantic (including Atlantic City) Counties, New Jersey, was designed to get women engaged in treatment and employment services, help them become sober, and successfully move to stable employment. CASASARD(SM) uses an innovative intensive case management approach to providing services for these women and compares it to the standard care approach that focus on employment first, screening and referral. Three hundred two participants were randomly assigned to each model (161 to intensive case management and 141 to standard care).

The demonstration and its results are also documented in a corresponding article, "Improving 24-Month Abstinence and Employment Outcomes for Substance-Dependent Women Receiving Temporary Assistance for Needy Families With Intensive Case Management", published in the February 2009 issue of the American Journal of Public Health (AJPH). The article finds that while women in the CASASARD(SM) demonstration program receiving standard care appeared to gain employment faster than those receiving intensive case management, they were not able to sustain these jobs over time.

The CASA report and AJPH article revealed that compared to women receiving standard care, the women receiving the intensive case management approach:

  • Received more time and services from their caseworkers;
  • Achieved rates three times as great of initiation, engagement, and retention in outpatient substance abuse treatment;
  • Achieved significant reductions in substance use with women receiving intensive case management and were almost twice as likely to be completely abstinent at the 12 and 24 month follow-ups compared to standard care women; and
  • Were more than twice as likely to be employed full-time at the end of two years.

"Risky substance use and addiction constitute this nation's number one public health problem. Our failure to prevent and treat it costs society more than $600 billion each year. These striking outcomes suggest that a long term care strategy of treatment and abstinence first create the conditions where employment can better be achieved and sustained, even among this seriously disabled population," said Joseph A. Califano, Jr., CASA's chairman and president and former U.S. Secretary of Health, Education, and Welfare. "CASASARD(SM) offers a promising new approach to reduce the human and economic costs of addiction to our welfare system and to achieve the goals of welfare reform throughout the nation."

Past CASA research has found that for each unemployed female welfare recipient with a substance use disorder who becomes substance-free and self-supporting, the economic benefit to society is about $48,000 annually in avoided welfare, health care and criminal justice costs, and contribution to the economy in employment. In New Jersey alone, this could amount to economic benefits of as much as $35 million per year.

"Due to the promising outcomes, the NJ Department of Human Services has expanded the CASASARD(SM) program to an additional 17 counties so we can serve even more mothers on welfare who have substance abuse problems. We hope our success can serve as a model to other states," said New Jersey Human Services Commissioner Jennifer Velez.

CASASARD(SM) is the first major system level test of the chronic disease management approach to addiction. Based on its success, the CASA White Paper recommends that:

  • All states adopt this intensive case management approach for women with substance use disorders.
  • Local and state agencies increase efforts to collaborate and coordinate services that support intensive case management.
  • The federal government support intensive case management through regulatory change and funding.

CASASARD(SM) represents the pioneering work of Jon Morgenstern, PhD., vice president and director of CASA's division of Health and Treatment Research and Analysis, other CASA researchers and collaborators of the New Jersey Department of Human Services, Rutgers University and the National Council on Alcohol and Drug Dependence. It was supported by federal funding from the National Institute on Drug Abuse and the Administration for Children and Families.

"CASA's evaluation reveals a finding of great importance to welfare administrators -- the ability of intensive case management to increase participation in treatment and retention thereby achieving abstinence, a necessary precondition of achieving any other welfare related goals," said Dr. Morgenstern.

The AJPH article was written by scientists from CASA and Rutgers University, Jon Morgenstern, Ph.D.; Charles Neighbors, Ph.D., M.B.A.; Alexis Kuerbis, MSW; Annette Riordan, Ph.D.; Kimberly Blanchard, Ph.D.; Katharine H. McVeigh, Ph.D.; Thomas J. Morgan, Psy.D.; and Barbara McCrady, Ph.D.

CASA is the only national organization that brings together under one roof all the professional disciplines needed to study and combat all types of substance abuse as they affect all aspects of society. CASA and its staff of more than 50 professionals has issued 67 reports and white papers, published one book, conducted demonstration programs focused on children, families and schools at 227 sites in 87 cities and counties in 34 states plus Washington, DC and two Native American tribal reservations, held 17 conferences attended by professionals and others from 49 states, and has been evaluating the effectiveness of drug and alcohol treatment in a variety of programs and drug courts. CASA is the creator of the nationwide initiative Family Day -- A Day to Eat Dinner With Your Children(TM) - the fourth Monday in September -- the 28th in 2009 -- that promotes parental engagement as a simple and effective way to reduce children's risk of smoking, drinking and using illegal drugs. In May 2007, CASA's Chairman Joseph A. Califano, Jr., called for a fundamental shift in the nation's attitude about substance abuse and addiction with publication of his book, HIGH SOCIETY: How Substance Abuse Ravages America and What To Do About It. For more information visit

* The National Center on Addiction and Substance Abuse at Columbia University is neither affiliated with, nor sponsored by, the National Court Appointed Special Advocate Association (also known as "CASA") or any of its member organizations, or any other organizations with the name of "CASA".

(1) CASA's Substance Abuse Research Demonstration program.

    Lauren Duran
    (212) 841-5260

    Sulaiman Beg
    (212) 841-5213

SOURCE The National Center on Addiction and Substance Abuse (CASA) at Columbia University
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Bruce E. Mosler, President and CEO of Cushman & Wakefield Elected to CASA* Board
2. Join Together(tm) Merges Into CASA*
3. New Williamsburg Health Evaluation Center, The Ultimate Investment In Future Health And Well-Being, Set To Open In March
4. Childrens cancer group recommends global evaluation system for neuroblastoma to improve treatment
5. Population Health Impact Institute Invites Organizations To Serve as Test Sites for Methods Evaluation Process(TM) (MEP(TM)) Accreditation Program:
6. TargetScan Evaluation is Shown to Deliver Potentially Higher Cancer Detection Rate and More Accurate Assessment of Grade
7. Bartlett Communications Launches Free Website Evaluation Tool for Small to Mid-Sized Businesses
8. Care Improvement Plus Achieves Top Scores for First SNP Evaluation Measures
9. Best Practice Database Provides Key Findings for Biopharma Product Launch Evaluation
10. Quigley Announces Completion of Phase IIb Clinical Study of QR-333 For Diabetic Peripheral Neuropathy on November 25, 2008; Collection and Evaluation of Study Data to Begin Immediately Thereafter
11. VA Announces Expansion of Disability Evaluation System Pilot
Post Your Comments:
(Date:10/13/2017)... Nevada (PRWEB) , ... October 13, 2017 , ... ... Hemp CBD Oil utilizing Purzorb™ technology. Applying the Purzorb™process to full spectrum CBD oil ... required and providing a CBD form that can be easily incorporated into liquid products, ...
(Date:10/13/2017)... SAN LUIS OBISPO, Calif. (PRWEB) , ... October 13, 2017 , ... ... with Alzheimer’s or dementia. However, many long-term care insurance companies have a waiver for ... mean is the 90-day elimination period, when the family pays for care, is often ...
(Date:10/13/2017)... ... ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh, has released a ... books in the Holy Scriptures, Revelation. The Book of Revelation paints a picture of ... have tossed it off as mere rubbish, but Yisrayl Hawkins says that is because ...
(Date:10/13/2017)... ... 2017 , ... “America On The Brink”: the Christian history of the United ... the creation of published author, William Nowers. Captain Nowers and his wife, Millie, ... spent thirty years in the Navy. Following his career as a naval aviator ...
(Date:10/12/2017)... WAUSAU, Wis. (PRWEB) , ... October 12, 2017 ... ... formulated standard products to meet the demand of today’s consumer and regulatory authorities ... team of probiotic experts and tested to meet the highest standard. , ...
Breaking Medicine News(10 mins):
(Date:9/28/2017)... Cohen Veterans Bioscience and Early Signal Foundation announce a ... sensors for real-time monitoring of patients with trauma-related and ... focused on disruptive health solutions for rare disorders and ... record and integrate behavioral, cognitive, physiological and contextual data. ... ...
(Date:9/25/2017)... R.I. , Sept. 25, 2017  EpiVax, ... assessment, vaccine design, and immune-engineering today announced the ... on the development of personalized therapeutic cancer vaccines. ... has provided exclusive access to enabling technologies to ... Eng., MBA will lead EpiVax Oncology as Chief ...
(Date:9/19/2017)... 2017 HistoSonics, Inc., a venture-backed medical device company developing a non-invasive, robotically assisted, ... three leadership team developments today:   ... ... Tom Tefft ... Veteran medical device executive Josh Stopek , PhD, who has ...
Breaking Medicine Technology: